---
figid: PMC8074527__gr1_lrg
figtitle: Mevalonate pathway involvement in viral mechanisms
organisms:
- Human immunodeficiency virus 1
- Severe acute respiratory syndrome coronavirus 2
- Hepatitis B virus
- Human gammaherpesvirus 4
- Influenza A virus
- Coronaviridae
- Human immunodeficiency virus
- Severe acute respiratory syndrome-related coronavirus
- Dengue virus
- Middle East respiratory syndrome-related coronavirus
- Respiratory syncytial virus
- Orthomyxoviridae
- H1N1 subtype
- Human gammaherpesvirus 8
- Vesicular stomatitis virus
- Zika virus
- West Nile virus
- H5N1 subtype
- Ebola virus
- Enterovirus C
- Human alphaherpesvirus 3
- H3N2 subtype
- Polyomavirus sp.
- Human betaherpesvirus 6
- Infectious bronchitis virus
- Betapolyomavirus hominis
- Mus musculus
- Rattus norvegicus
- Listeria monocytogenes
- Gracilinema caldarium
- Homo sapiens
- Canis lupus familiaris
- Candida dubliniensis
- NA
- NA
- NA
pmcid: PMC8074527
filename: gr1_lrg.jpg
figlink: pmc/articles/PMC8074527/figure/f0005/
number: F1
caption: Overview of the mevalonate pathway involvement in viral mechanisms. (A) Pharmacological
  inhibition of the mevalonate pathway enzymes alters the synthesis of isoprenoid
  intermediates and of the end-product cholesterol, affecting key steps of viral life
  cycle. (B) Summary of pros and cons in the use of Statins (orange) and Bisphosphonates
  (blue) in viral infections. (For interpretation of the references to color in this
  figure legend, the reader is referred to the web version of this article.)
papertitle: 'Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts
  and potential therapeutic targets.'
reftext: Maria Chiara Proto, et al. Prog Lipid Res. 2021 Apr 26 ;82:101099-101099.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9487802
figid_alias: PMC8074527__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Canis lupus familiaris
redirect_from: /figures/PMC8074527__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8074527__gr1_lrg.html
  '@type': Dataset
  description: Overview of the mevalonate pathway involvement in viral mechanisms.
    (A) Pharmacological inhibition of the mevalonate pathway enzymes alters the synthesis
    of isoprenoid intermediates and of the end-product cholesterol, affecting key
    steps of viral life cycle. (B) Summary of pros and cons in the use of Statins
    (orange) and Bisphosphonates (blue) in viral infections. (For interpretation of
    the references to color in this figure legend, the reader is referred to the web
    version of this article.)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HCC
  - HYCC1
  - KRT88P
  - IPP
  - FDPS
  - MSX2
  - PROS1
  - TRPV4
  - SMN1
  - RHOA
  - AGFG1
  - RAB10
  - RAB11A
  - RAB11B
  - RAB12
  - RAB13
  - RAB14
  - RAB15
  - RAB17
  - RAB18
  - RAB19
  - RAB1A
  - RAB1B
  - RAB1C
  - RAB20
  - RAB21
  - RAB22A
  - RAB23
  - RAB24
  - RAB25
  - RAB26
  - RAB27A
  - RAB27B
  - RAB28
  - RAB2A
  - RAB2B
  - RAB30
  - RAB31
  - RAB32
  - RAB33A
  - RAB33B
  - RAB34
  - RAB35
  - RAB36
  - RAB37
  - RAB38
  - RAB39A
  - RAB39B
  - RAB3A
  - RAB3B
  - RAB3C
  - RAB3D
  - RAB40A
  - RAB40AL
  - RAB40B
  - RAB40C
  - RAB41
  - RAB42
  - RAB43
  - RAB44
  - RAB4A
  - RAB4B
  - RAB5A
  - RAB5B
  - RAB5C
  - RAB6A
  - RAB6B
  - RAB6C
  - RAB7A
  - RAB7B
  - RAB29
  - RAB8A
  - RAB8B
  - RAB9A
  - RAB9B
  - RABL2A
  - RABL2B
  - RABL3
  - IFT22
  - RHOB
  - Hmgcr
  - Ipp
  - Fdps
  - Loca1
  - Rhoa
  - Agfg1
  - Rhob
  - Pros1
  - Statins
  - Acetyl-CoA
  - Atorvastatin
  - Simvastatin
  - Lovastatin
  - Fluvastatin
  - Rosuvastatin
  - Mevalonate
  - BPs
  - Alendronate
  - Squalene
  - FPP
  - Pamidronate
  - Zoledronic acid
  - Cholesterol
  - Myopathies
  - myalgia
  - rhabdomyolysis
  - respiratory diseases
  - liver failure
  - HBC/HVC
  - HIV
  - kidney injuries
  - Hypocalcemia
  - hypophosphatemia
  - bone dysfuction
  - HBV
---
